¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nuclear cycle"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • infection cycle
    °¨¿°°í¸®, °¨¿°»ç
  • life cycle
    »ýȰÁÖ±â
  • mitotic cycle
    À¯»çºÐ¿­ÁÖ±â
  • metabolic cycle
    ´ë»çÁÖ±â
  • nasal cycle
    ÄÚ¼øÈ¯°úÁ¤, ÄÚÁÖ±â
  • nitrogen cycle
    Áú¼Ò¼øÈ¯, Áú¼Ò»çÀÌŬ
  • oogenetic cycle
    ³­¼ÒÁÖ±â
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovulation cycle
    ¹è¶õÁÖ±â
  • photochemical cycle
    ±¤È­ÇÐȸ·Î
  • pulse cycle
    ¸Æ¹ÚÁÖ±â
  • pain-spasm-pain cycle
    ÅëÁõ¿¬ÃàÅëÁõÁÖ±â
  • reproduction cycle
    »ý½ÄÁÖ±â
  • reversible cycle
    °¡¿ªÈ¸·Î
  • sporogenous cycle
    Ȧ¾¾Çü¼º±â, Æ÷ÀÚÇü¼º±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • gravitational cycle
    ÀÓ½ÅÁÖ±â
  • growth cycle
    Áõ½ÄÁÖ±â
  • infection cycle
    °¨¿°»ç, °¨¿°°í¸®
  • life cycle
    »ýȰÁÖ±â, »ýȰ°í¸®
  • metabolic cycle
    ´ë»çÁÖ±â
  • mitotic cycle
    À¯»çºÐ¿­ÁÖ±â
  • nasal cycle
    ÄÚ¼øÈ¯°úÁ¤, ÄÚÁÖ±â
  • oogenetic cycle
    (¢¡ovarian cycle) ³­¼ÒÁÖ±â
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovulation cycle
    ¹è¶õÁÖ±â
  • photochemical cycle
    ±¤È­ÇÐȸ·Î
  • pulse cycle
    ¸Æ¹ÚÁÖ±â
  • reproduction cycle
    »ý½ÄÁÖ±â
  • reversible cycle
    °¡¿ªÈ¸·Î
  • sexual cycle
    ¼ºÁÖ±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • menstrual cycle, anovulatory
    ¿ù°æÁÖ±â(êÅÌèñÎÑ¢), ¹«¹è¶õ¼º(ÙíÛÉÕ°àõ)
  • metabolic cycle
    ´ë»çÁÖ±â.
  • mitotic cycle
    À¯»çºÐ¿­È¯(¡­ü»).
  • mitotic cycle
    À¯»çºÐ¿­ÁÖ±â
  • nitrogen cycle
    Áú¼Òȸ·Î.
  • nitrogen cycle
    Áú¼Ò¼øÈ¯ (»ýŰ賻)
  • oestrus cycle
    ¹ßÁ¤ÁÖ±â(Û¡ï×ñÎÑ¢).
  • oogenetic cycle =ovarian c.
    ³­Àڹ߻ýÁÖ±â(Õ°í­Û¡ßæñÎÑ¢).
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovulation cycle
    ¹è¶õÁÖ±â(¡­ñÎÑ¢).
  • oxygen cycle
    »ê¼Òȸ·Î.
  • photochemical cycle
    ±¤È­Çаæ·Î(¡­ÌèÖØ).
  • pulse cycle
    ¸Æ¹ÚÁÖ±â(ØæÚÑñ²Ñ¢).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • purine cycle
    Ǫ¸° ȸ·Î(üÞÖØ)
  • purine nucleotide cycle
    Ç»¸° ´©Å¬·¹¿ÀŸÀ̵å ȸ·Î(üÞÖØ)
  • putrescine cycle
    ǪƮ·¹½Å ȸ·Î(üÞÖØ)
  • pyridine nucleotide cycle
    ÇǸ®µò ´©Å¬·¹¿ÀŸÀ̵å ȸ·Î(üÞÖØ)
  • Q cycle
    Q ȸ·Î(üÞÖØ)
  • quinone cycle
    Äû³í ȸ·Î(üÞÖØ).
  • reductive carboxylic acid cycle
    ȯ¿ø¼º(ü½êªàõ) Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ)
  • reductive pentose cycle
    ȯ¿ø¼º(ü½êªàõ) ÆæÅ佺 ȸ·Î(üÞÖØ)
  • reductive pentose phosphate cycle
    ȯ¿ø¼º(ü½êªàõ) Àλê(×òß«)ÆæÅ佺 ȸ·Î(üÞÖØ)
  • reductive tricarboxylic acid cycle
    ȯ¿ø¼º(ü½êªàõ) Æ®¸®Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ)
  • rhodopsin cycle
    ·Îµ½½Å ȸ·Î
  • ribosome cycle
    ¶óÀ̺¸¼Ø ȸ·Î(üÞÖØ)
  • Shemin cycle
    ½¦¹Î ȸ·Î(üÞÖØ)
  • sigma cycle
    ½Ã±×¸¶È¸·Î(üÞÖØ)
  • substrate cycle
    ±âÁúȸ·Î (ÐñòõüÞÖØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
Tc cytotoxic T-cell; the generation time of a cell cycle; tricuspid closure
tG1 the time required to complete the G1 phase of the cell cycle
tG2 the time required to complete the G2 phase of the cell cycle
tM the time required to complete the M phase of the cell cycle
tS time required to complete the S phase of the cell cycle
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
(13)C NMR 13)C nuclear magnetic resonance
NMR 13)C-nuclear magnetic resonance
(31)P NMR 31)P nuclear magnetic resonance
NMR 31)P-nuclear magnetic resonance
31PNMR 31-Phosphorus nuclear magnetic resonance
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
forced cycle <cardiology, physiology> A cardiac cycle (atrial or ventricular) that is cut short by a forced beat.
(05 Mar 2000)
fuel cycle The series of steps required to produce electricity. The fuel cycle includes mining or otherwise acquiring the raw fuel source, processing and cleaning the fuel, transport, electricity generation, waste management and plant decommissioning.
(05 Dec 1998)
futile cycle <biochemistry> Any seqence of enzyme catalysed reactions in which the forward and reverse processes (catalysed by different enzymes) are consititutively active.
Frequently used to describe the cycle of phosphorylation and dephosphorylation of phosphatidyl inositol derivatives in cell membranes.
(05 Jan 1998)
levelised life-cycle cost The present value of the cost of a resource, including capital, financing and operating costs, expressed as a stream of equal annual payments. This stream of payments can be converted to a unit cost of energy by dividing the annual payment amount by the annual kilowatt-hours produced or saved. By levelizing costs, resources with different lifetimes and generating capabilities can be compared.
(05 Dec 1998)
life cycle The entire life history of a living organism.
(05 Mar 2000)
life-cycle costing A method of comparing costs of equipment or buildings based on original costs plus all operating and maintenance costs over the useful life of the equipment. Future costs are discounted.
(05 Dec 1998)
life cycle stages The continuous sequence of changes undergone by metamorphosing insects and other animals during the developmental process.
(12 Dec 1998)
lytic cycle The general life cycle of a lytic virus, from infection of the host cell, hijacking of the host cells mechanisms, use of the host cells mechanisms to produce viral components, and assembly of the components into progeny viruses, to the destruction of the host cell by rupturing its plasma membrane (lysis) and the release of the progeny viruses so that they can spread and infect other cells.
(09 Oct 1997)
receptors, cytoplasmic and nuclear Proteins in the cytoplasm or nucleus that specifically bind signalling molecules and trigger changes which influence the behaviour of cells. The major groups are the steroid hormone receptors, which usually are found in the cytoplasm, and the thyroid hormone receptors, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands.
(12 Dec 1998)
Remak's nuclear division <cell biology> An unusual form of nuclear division, in which the nucleus simply constricts, rather like a cell without chromosome condensation or spindle formation. Partitioning of daughter chromosomes is haphazard. Observed in some Protozoa.
(18 Nov 1997)
Pelger-Huet nuclear anomaly Congenital inhibition of lobulation in the nuclei of neutrophilic leukocytes; most cells present band or bilobulate appearance, and only an occasional cell is trilobed; it is not associated with disease, but may be confused with leukocyte "shift to left"; autosomal dominant inheritance.
(05 Mar 2000)
ribonucleoproteins, small nuclear Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm. The u3 snrnp is localised in the nucleolus, where it aligns into base pairs with the 28s rrna precursor in a still unidentified region and functions in pre-rrna processing. The u7 snrnp aligns into base pairs with a conserved sequence in the 3'-end of histone pre-mRNA and is an essential cofactor for the cleavage that creates the mature nonadenylated 3'-end.
(12 Dec 1998)
RNA, heterogeneous nuclear Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesised and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnrna hybridises with nuclear DNA rather than with mRNA.
(12 Dec 1998)
RNA, nuclear RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm.
(12 Dec 1998)
RNA, small nuclear Short chains of RNA found in the nucleus. Their function is to remove the introns (nontranslated intervening sequences) from mRNA precursors, thereby bringing the two exons (coding segments) together into correct juxtaposition for enzymatic splicing at the correct point. The resulting mRNA is now ready to leave the nucleus.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á